Legend Capital invests in Series A funding round of BioMap, a biological computing platform
HONG KONG, July 30, 2021 - (ACN Newswire) - BioMap, a biological computing platform enterprise, has recently completed the Series A funding round worth over a hundred million US dollars, which Legend Capital participated in. The funds will be used to for R&D and talent recruitment.
BioMap is positioned as an innovative medicine R&D platform driven by biological computing engine. It was co-founded by Robin Li in November 2020 and he currently serves as the Chairman. Through advanced computing and biotechnology, BioMap draws maps on disease targets and drug design to realize the Global First-in-class original drugs. In the future, BioMap will also focus on the field of immune mechanism of tumors, autoimmune diseases and fibrotic diseases.
Legend Capital Invests In Series A Funding Round Of BioMap, A Biological Computing Platform
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Business Scoop » Legend Capital Invests In Series A Funding Round Of BioMap, A Biological Computing Platform
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.